Markers of cerebrovascular injury, inflammation, and plasma lipids are associated with Alzheimer’s disease cerebrospinal fluid biomarkers in cognitively normal persons

Manuscript Number: 

21-5400R1

Author(s): 
Michelle A. Erickson, Jeffrey J. Iliff, Deidre Jansson, Ge Li, Elaine R. Peskind, Ron Thomas, Marie Wang

Disclosures

Michelle A. Erickson

  • Nothing to Disclose

Jeffrey J. Iliff

  • Nothing to Disclose

Deidre Jansson

  • Nothing to Disclose

Ge Li

  • Nothing to Disclose

Elaine R. Peskind

  • Consulting Fees:
    Chair, DSMB, Eli Lilly Phase III Study of Donanemab anti-amyloid monoclonal antibody Acadia - Scientific Advisory Board for pimavanserin for dementia related psychosis Avanir - Scientific Advisory Board for l-dextromethorphan + quinidine clinical trial in traumatic brain injury
    Equity:
    Approximately $1500 of Bristol Myers Squibb stock
    Lecture Fees:
    Acadia - dementia related psychosis - approximately $5,000 in 2019
    Patents/Royalties
    Expert witness for cases involving undue influence and testamentary capacity - unrelated to this manuscript.

Ron Thomas

  • Nothing to Disclose

Marie Wang

  • Nothing to Disclose